JCNRJournal of Clinical and Nursing Research2208-36852208-3693Bio-Byword Scientific Publishing Pty. Ltd.10.26689/jcnr.v8i6.7643ArticleInvestigation of the Cytotoxicity of CAR-NK-92 Cells Targeting CEA Against Gastric Cancer Cellshttps://artdesignp.com/journal/JCNR/8/6/10.26689/jcnr.v8i6.7643ZhengXinyu,ZhouXiaoxiao,XiaXingzhou,ChenXiaomeng2024862024-07-18Objective: To construct CAR-NK-92 cells targeting carcinoembryonic antigen (CEA) and study their killing effect on gastric cancer cells. Methods: CAR-NK-92 cells targeting CEA were constructed. After co-culturing CAR-NK-92 cells with MKN-45 gastric cancer cells, the killing effect of CAR-NK-92 cells was detected by a lactate dehydrogenase release assay. The secretion levels of gamma interferon and granulocyte-macrophage colony-stimulating factor were measured using an ELISA assay. Results: The lactate dehydrogenase release assay showed that CAR-NK-92 cells had a significant killing effect on MKN-45 cells compared to CON-NK-92 cells, and the difference was statistically significant (P < 0.001). ELISA results indicated that the levels of gamma interferon and granulocyte-macrophage colony-stimulating factor secreted by CAR-NK-92 cells and MKN-45 target cells were significantly increased after co-culture (P < 0.001). Conclusion: CAR-NK-92 cells targeting CEA exhibit a significant killing effect on CEA-positive gastric cancer cells.

Smyth EC, Nilsson M, Grabsch HI, et al., 2020, Gastric Cancer. Lancet, 396(10251): 635–648. https://doi.org/10.1016/S0140-6736(20)31288-5

Liu S, Chen L, Xia A, et al., 2023, Research Progress of CAR-NK Cell Therapy for Hepatocellular Carcinoma. Journal of Nanjing Medical University (Natural Sciences), 43(5): 595–603 + 647. https://doi.org/10.7655/NYDXBNS20230502

Zabel M, Tauber P, Pickl W, 2019, The Making and Function of CAR Cells. Immunol Lett, 212: 53–69.doi:10.1016/j.imlet.2019.06.002

Yan J, Yin G, Deng G, 2023, Research Progress of CAR-NK in the Treatment of Solid Tumors. Journal of Modern Oncology, 31(5): 964–968. https://doi.org/10.3969/j.issn.1672-4992.2023.05.035

Guillerey C, 2020, NK Cells in the Tumor Microenvironment. Adv Exp Med Biol, 1273: 69–90. doi:10.1007/978-3-030-49270-0_4

Farag S, Caligiuri M, 2006, Human Natural Killer Cell Development and Biology. Blood Rev, 20(3): 123–137. doi:10.1016/j.blre.2005.10.001

Liu E, Marin D, Banerjee P, et al., 2020, Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors. N Engl J Med, 382(6): 545–553. doi:10.1056/NEJMoa1910607

Li Y, Orange J, 2021, Degranulation Enhances Presynaptic Membrane Packing, Which Protects NK Cells from Perforin-Mediated Autolysis. PLoS Biol, 19(8): e3001328. doi:10.1371/journal.pbio.3001328